A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their impact on the brain, pointing to benefits from addiction to schizophrenia.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.